Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON27242Recruiting
Open-label, single-arm trial, sponsored by Institute for Applied Epistemology and Medical Methodology. Primary endpoint: Frequency of reported adverse drug reactions relative to total sales volume. Started Nov 2018; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON27242.